Literature DB >> 10195753

Lymphocyte kinetics and precursor frequency-dependent recovery of CD4(+)CD45RA(+)CD62L(+) naive T cells following triple-drug therapy for HIV type 1 infection.

R L Hengel1, B M Jones, M S Kennedy, M R Hubbard, J S McDougal.   

Abstract

New therapeutic regimens have dramatically altered morbidity and mortality attributed to HIV-1 infection. Changes in lymphocyte subsets after treatment may mirror salutary clinical changes. Over 4 months we analyzed lymphocyte subsets in 20 patients starting new HIV-1 therapy. Absolute numbers of lymphocytes, CD4+ T cells, CD8+ T cells, and B cells increased significantly by 4 months, but CD8+ T cell and B cell increases were restricted to late-stage patients. Subset analysis revealed that the magnitude of recovering naive-phenotype CD4+ T cells (slope) correlated with the number of these cells present at baseline, equaling or exceeding the memory-phenotype slope within days if these naive cells were abundant at baseline. Five of 10 patients in whom naive-phenotype CD4+ T cells were absent at baseline partially repopulated these cells by 4 months. These findings have important implications for the origin and mechanisms of renewal of naive-phenotype CD4+ T cells following effective treatment for HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195753     DOI: 10.1089/088922299311187

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  4 in total

1.  Proliferative responses of blood mononuclear cells (BMNC) in a cohort of elderly humans: role of lymphocyte phenotype and cytokine production.

Authors:  H Bruunsgaard; A N Pedersen; M Schroll; P Skinhøj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV.

Authors:  Timothy W Schacker; Ronald J Bosch; Kara Bennett; Richard Pollard; Gregory K Robbins; Ann C Collier; Roy M Gulick; John Spritzler; Donna Mildvan
Journal:  J Acquir Immune Defic Syndr       Date:  2010-05-01       Impact factor: 3.731

3.  Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.

Authors:  Dwight E Yin; Meredith G Warshaw; William C Miller; Hannah Castro; Susan A Fiscus; Lynda M Harper; Linda J Harrison; Nigel J Klein; Joanna Lewis; Ann J Melvin; Gareth Tudor-Williams; Ross E McKinney
Journal:  Pediatrics       Date:  2014-10       Impact factor: 7.124

4.  Systemic Cytokine Levels Do Not Predict CD4(+) T-Cell Recovery After Suppressive Combination Antiretroviral Therapy in Chronic Human Immunodeficiency Virus Infection.

Authors:  Philip J Norris; Jinbing Zhang; Andrew Worlock; Sangeetha V Nair; Kathryn Anastos; Howard L Minkoff; Maria C Villacres; Mary Young; Ruth M Greenblatt; Seema Desai; Alan L Landay; Stephen J Gange; C Thomas Nugent; Elizabeth T Golub; Sheila M Keating
Journal:  Open Forum Infect Dis       Date:  2016-02-08       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.